Evidence-based medical research on Chinese medicine based on mind-body treatment of irritable bowel syndrome

Authors
Category Primary study
Registry of TrialsITMCTR
Year 2024
INTERVENTION: IBS‐D acupuncture and moxibustion group:acupuncture and moxibustion;IBS‐D Western medicine group:Western medicine;IBS‐C acupuncture and moxibustion group:acupuncture and moxibustion;IBS‐C Chinese Medicines+acupuncture group:Chinese Medicines+acupuncture;IBS‐D Chinese Medicines Group:Chinese Medicines;IBS‐C Chinese Medicines Group:Chinese Medicines;IBS‐D Chinese Medicines+acupuncture group:Chinese Medicines+acupuncture;IBS‐C Western medicine group:Western medicine; CONDITION: irritable bowel syndrome PRIMARY OUTCOME: Overall Clinical Efficacy Rating; SECONDARY OUTCOME: Psychological assessmen;Assessment of symptom severity;Grading of Chinese Medicine Symptoms;Quality of life assessment; INCLUSION CRITERIA: (1) Comply with the diagnostic criteria of IBS‐D and IBS‐C in Chinese and Western medicine; (2) PSSS score: male =10 points, female =11 points. (3) Age: 18‐80 years old, gender is not limited; (4) Informed consent and voluntary participation in the study.
Epistemonikos ID: 6dd82642fa344ce23e1892b463458924bf61da40
First added on: Aug 28, 2024